Health Care & Life Sciences » Pharmaceuticals | GelStat Corp.

GelStat Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2010
2011
2012
2013
2014
Sales/Revenue
2.10
7.10
21.40
15.90
1,312.70
Cost of Goods Sold (COGS) incl. D&A
1.40
1.70
9.20
12.40
1,090.80
Gross Income
0.70
5.40
12.30
3.50
221.90
SG&A Expense
262.40
557.50
416.90
413.30
1,524.20
EBIT
261.70
552.10
404.70
409.80
1,302.30
Unusual Expense
-
-
868.80
-
-
Non Operating Income/Expense
-
-
-
2.40
8.70
Interest Expense
42.20
15.40
-
-
3.90
Pretax Income
303.90
567.50
464.10
407.40
1,297.50
Consolidated Net Income
303.90
567.50
464.10
407.40
1,297.50
Net Income
303.90
567.50
464.10
407.40
1,297.50
Net Income After Extraordinaries
332.00
838.50
464.10
407.40
1,297.50
Net Income Available to Common
303.90
567.50
464.10
407.40
1,297.50
EPS (Basic)
0.01
0.00
0.00
0.00
0.00
Basic Shares Outstanding
43,519.70
70,845.20
122,538.50
147,533.40
340,340.90
EPS (Diluted)
0.01
0.00
0.00
0.00
0.00
Diluted Shares Outstanding
43,519.70
70,845.20
135,373.50
147,533.40
340,340.90
EBITDA
260.40
550.80
403.40
408.40
1,244.40

About GelStat

View Profile
Address
10711 Gilroy Road
Hunt Valley Maryland 21031
United States
Employees -
Website http://www.gelstat.com
Updated 07/08/2019
GelStat Corp. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes GelStat Migraine, Chews 2 Lose, All Natural Speed, and GelStat Speed. The company was founded on November 13, 1991 and is headquartered in Hunt Valley, MD.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.